Skip to main content
TipRanks
Go Ultimate75% OFF

Vicore Pharma Holding AB Sponsored ADR (VCRE) Financial Statements

3 Followers

Vicore Pharma Holding AB Sponsored ADR Financial Overview

Vicore Pharma Holding AB Sponsored ADR's market cap is currently kr284.42M. The company's EPS TTM is kr-5.92; its P/E ratio is -5.47; Vicore Pharma Holding AB Sponsored ADR is estimated to report earnings on February 25, 2027, and the estimated EPS forecast is kr-0.53. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25
Income Statement
Total Revenuekr 3.82M
Gross Profitkr 3.82M
Operating Incomekr -454.44M
EBITDAkr -477.41M
Net Incomekr -477.47M
Balance Sheet
Cash & Short-Term Investmentskr 1.17B
Total Assetskr 1.22B
Total Debtkr 0.00
Net Debtkr -578.15M
Total Liabilitieskr 123.17M
Stockholders' Equitykr 1.10B
Cash Flow
Free Cash Flowkr -375.74M
Operating Cash Flowkr -375.74M
Investing Cash Flowkr -600.51M
Financing Cash Flowkr 430.54M

Currency in SEK

Vicore Pharma Holding AB Sponsored ADR Earnings and Revenue History

-600M-300M0300M-12511 %-12510 %-12509 %-12508 %EarningsProfit Margin2025RevenueEarningsProfit Margin

Vicore Pharma Holding AB Sponsored ADR Liabilities to Assets

0500M1B1.5B9 %10 %11 %12 %LiabilitiesLiabilities to Assets2025AssetsLiabilitiesLiabilities to Assets

Vicore Pharma Holding AB Sponsored ADR Cash Flow

-750M-500M-250M0250M500M2025OperatingInvestingFinancing

Vicore Pharma Holding AB Sponsored ADR Forecast EPS vs Actual EPS

-0.6-0.6-0.5-0.5-0.4-0.4-0.3Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss